Neuroimaging standards for research into small vessel disease—advances since 2013Marco Duering, Hugh S. Markus, Rustam Al‐Shahi Salman et al.|The Lancet Neurology|2023Cited by 962
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy studyAndreas Charidimou, M. Edip Gurol, Steven M. Greenberg et al.|The Lancet Neurology|2022Cited by 651
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral AnticoagulantsThomas R. Meinel, Madlaine Mueller, Duncan Wilson et al.|JAMA Neurology|2023Cited by 119
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non–Vitamin K Antagonist Oral Anticoagulants for Stroke PreventionMaurizio Paciaroni, Simona Marcheselli, Giancarlo Agnelli et al.|Stroke|2019Cited by 95
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND StudyMaurizio Paciaroni, Lucia Pavolucci, Valeria Caso et al.|Stroke|2022Cited by 73